The global molecular imaging market is witnessing steady growth as healthcare providers increasingly adopt advanced diagnostic technologies to enable earlier disease detection and improve patient outcomes. Valued at USD 8.92 billion in 2025, the market is projected to reach USD 12.94 billion by 2034, expanding at a CAGR of 4.22% during the forecast period.

Molecular imaging has become an essential component of modern healthcare by allowing clinicians to visualize biological processes at the cellular and molecular levels before structural abnormalities become apparent. The technology plays a critical role in oncology, cardiology, neurology, and drug development while supporting the growing shift toward precision medicine. Continuous innovation in hybrid imaging systems, artificial intelligence, and radiopharmaceuticals is further strengthening market expansion worldwide.

Click to Read the Complete Insights & Report:https://straitsresearch.com/re....port/molecular-imagi